These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11321147)
1. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Shaikh S; Blumenkranz MS Retina; 2001; 21(2):176-8. PubMed ID: 11321147 [No Abstract] [Full Text] [Related]
2. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®. Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185 [TBL] [Abstract][Full Text] [Related]
3. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Degenring RF; Kamppeter B; Kreissig I; Jonas JB Acta Ophthalmol Scand; 2003 Aug; 81(4):399-401. PubMed ID: 12859269 [No Abstract] [Full Text] [Related]
4. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions. Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Udaondo P; Garcia-Delpech S; Salom D; Garcia-Pous M; Díaz-Llopis M Am J Ophthalmol; 2011 Aug; 152(2):326-7; author reply 327-8. PubMed ID: 21784203 [No Abstract] [Full Text] [Related]
7. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Degenring RF; Kamppeter B; Kreissig I; Jonas JB Acta Ophthalmol Scand; 2003 Oct; 81(5):548-50. PubMed ID: 14510813 [No Abstract] [Full Text] [Related]
8. Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment. Lockington D; Imrie F; Gillen J; Fitzpatrick A; Willison H Can J Ophthalmol; 2010 Dec; 45(6):649. PubMed ID: 20935688 [No Abstract] [Full Text] [Related]
9. DEXAMETHASONE IMPLANT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION IN PATIENTS YOUNGER THAN 50 YEARS. Battaglia Parodi M; Iacono P; Sacconi R; Parravano M; Varano M; Bandello F Retina; 2015 Jul; 35(7):1381-6. PubMed ID: 26102437 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Sakuma T; Mizota A; Inoue J; Tanaka M Am J Ophthalmol; 2010 Dec; 150(6):876-82. PubMed ID: 20801424 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Ehlers JP; Decroos FC; Fekrat S Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943 [TBL] [Abstract][Full Text] [Related]
12. [Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions]. Niederhauser N; Valmaggia C Klin Monbl Augenheilkd; 2013 Apr; 230(4):405-8. PubMed ID: 23629792 [TBL] [Abstract][Full Text] [Related]
13. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice. Matonti F; Meyer F; Guigou S; Barthelemy T; Dumas S; Gobert F; Hajjar C; Merite PY; Parrat E; Rouhette H; Pommier S Acta Ophthalmol; 2013 Nov; 91(7):e584-6. PubMed ID: 23764276 [No Abstract] [Full Text] [Related]
14. The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema. Kola M; Hacioglu D; Turk A; Erdol H Cutan Ocul Toxicol; 2016 Sep; 35(3):185-9. PubMed ID: 26340259 [TBL] [Abstract][Full Text] [Related]
15. [Ozurdex, modern therapy for macular edema in central retinal vein occlusion]. Blajan C; Nicula D Oftalmologia; 2012; 56(3):40-5. PubMed ID: 23713337 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000 [TBL] [Abstract][Full Text] [Related]
17. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION. Lotfy A; Solaiman KAM; Abdelrahman A; Samir A Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561 [TBL] [Abstract][Full Text] [Related]
19. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion. Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824 [TBL] [Abstract][Full Text] [Related]
20. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion. Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]